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Summary
Background The aim of the study was to examine the correlation of the conventional method of arterial pressure 
measurement in the brachial artery and non-invasive aortic pressure measurement by applanation tonometry with 
vascular and left ventricular structure and function. An attempt was made at determining a correlation of morpho-
logical and functional changes within the cardiovascular system with selected parameters of renal filtration function 
and the renal interstitium in patients with previously untreated primary arterial hypertension.
Material and methods 25 patients with untreated primary arterial hypertension without albuminuria and 15 
healthy volunteers underwent arterial pressure measurement with a standard mercury sphygmomanometer using 
the Korotkoff technique and non-invasive measurement of aortic pressure by applanation tonometry using a Sphy-
gmoCor device. For all subjects, the concentrations of creatinine, uric acid, 1,25(OH)2D3, erythropoietin, and 25- 
-hour NAG excretion were determined and GFR was estimated using the MDRD equation. PWV measurement 
was performed using a SphygmoCor device, whereas IMT was measured by ultrasound.
Results Hypertensive patients showed higher values of arterial pressure compared to the control group: SBP, DBP, 
PP, MAP, as well as CSP, CDP, CPP and MCAP. In both the studied and the control group, the following statistically 
significant positive correlations were found: CPP vs IMT and CPP vs AIx.
Only in the studied group, the following positive linear correlations were found: NAG vs PWV (R = 0.46; p = 0.019); 
NAG vs IMT (R = 0.36; p = 0.078). In the multiple regression model, a statistically significant positive effect was found 
of PWV and IMT [PWV (b 0.41; p = 0.0158), IMT (b 0.49; p = 0.0048)] on the dependent variable NAG (R2 =  
= 0.503) in hypertensive patients. eGFR or uric acid concentration in serum included additionally in the model had no 
statistically significant effect on the dependent variable NAG (p = 0.9307 and p = 0.4938, respectively).
Conclusions Damage to the renal tubulointerstitial tissue in hypertensive patients is concomitant with a decrease in 
vascular resistance. CPP may constitute a useful parameter for assessing the development of atherosclerotic lesions 
in vessels and the function of the left ventricle of the heart.
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Background
Arterial hypertension constitutes one of the most 
critical risk factors for complications affecting the 
cardiovascular system. Recognized as one of the most 
common chronic diseases, it poses a major medical, 
social and economic problem.
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Measuring central blood pressure in patients with 
arterial hypertension attracts growing attention due 
to its predictive value in terms of cardiovascular 
events, as well as the varying effects of antihyper-
tensive drugs on central pressure as compared to 
brachial artery pressure. Conventional sphygmoma-
nometry employed as a  fundamental method for 
measuring arterial blood pressure allows obtaining 
the values of systolic and diastolic pressure solely in 
the brachial artery. Arterial pressure measurement 
carried out using the traditional method does not 
reflect the actual pressure in the aorta or the left ven-
tricle during systole.
Systolic blood pressure (SBP) and pulse pressure 
(PP) in the brachial artery are physiologically higher 
than central systolic pressure (CSP) and central pulse 
pressure (CPP) [1]. In contrast, brachial diastolic 
blood pressure (DBP) is slightly lower than central 
diastolic pressure (CDP), but the values are almost 
identical with respect to mean pressure [1].
A difference of 6–11 mmHg in the values of CSP 
and CPP between the carotid artery and the brachial 
artery was found in a study by Safar et al. [2], carried 
out on a group of patients receiving long-term treat-
ment for arterial hypertension. Pressure augmenta-
tion was significantly lower in a  group of patients 
with optimal and normal arterial pressure (6.6– 
–8.6 mmHg for SBP and 6.8–7.4 mmHg for PP) as 
compared to a group of patients with normal-high 
arterial pressure and stage 1, 2 and 3 hypertension 
(9.7–11.3 mmHg for SBP and 10.1–11.3 mmHg for 
PP) determined from measurements in the brachial 
artery [2].
Despite the fact that central pressure seems to be 
more effective in estimating the risk of cardiovas-
cular complications of hypertension than the value 
obtained through standard measurement in the bra-
chial artery, current guidelines on the diagnosis and 
treatment of hypertension are based solely on the 
conventional pressure measurement method [3]. 
This might result from the fact that normal central 
pressure values have not been determined and that 
the correlations between central and peripheral ar-
terial pressure in different populations or age groups 
have not been discovered as yet. A study carried out 
by McEniery et al. [4] found that CSP in a group of 
patients with normal systolic pressure (SBP in the 
range of 120–129 mmHg) measured by the oscil-
lometric method in the brachial artery fell within 
the value range of approximately 90–125 mmHg, 
whereas in a group of patients with stage 1 hyper-
tension (SBP in the range of 140–159 mmHg) CSP 
was approximately 110–158 mmHg. With respect 
to the classification of arterial hypertension based 
on the conventional measurement method, 32% of 
men and 10% of women with normal SBP had the 
same values of CSP as patients with stage 1 hyper-
tension [4]. The results suggest that the total risk for 
cardiovascular events may be estimated inaccurately 
in patients with arterial hypertension classified sole-
ly on the basis of conventional measurements in the 
brachial artery. Some of the patients whose pressure 
is classified as normal on the basis of conventional 
sphygmomanometry measurements may actually 
be at a  higher cardiovascular risk resulting from 
the value of central pressure. Likewise, in patients 
with increased brachial systolic pressure and nor-
mal central pressure, arterial pressure measurement 
based solely on the conventional method may over-
estimate cardiovascular risk and lead to administer-
ing too intensive antihypertensive pharmacological 
treatment. 
Currently, much attention is focused on the es-
timation of early complications developing in the 
course of arterial hypertension. Owing to the in-
troduction of novel, non-invasive diagnostic meth-
ods, significant advancements have been made al-
lowing assessing the structure and function of the 
cardiovascular system. This makes it possible to 
estimate early changes within the cardiovascular 
system preceding the development of atherosclero-
sis in patients with primary arterial hypertension. 
A significant role in assessing the degree of arterial 
wall remodelling is played by measurement of ca-
rotid intima-media thickness (IMT) by Doppler 
ultrasound and measurement of aortal pulse wave 
velocity (PWV) between the carotid and the fem-
oral artery. 
A  special role in the complex, multifactorial 
pathogenesis of primary arterial hypertension is 
assigned to the regulation of sodium and water 
excretion by the kidneys [5]. Changes in arte-
rial hypertension result in subtle changes in re-
nal blood flow which in turn lead to significant 
changes in sodium and water excretion through 
the kidneys, and thus make it imperative that ar-
terial pressure be maintained at a constant level. 
An impairment of renal mechanisms regulating 
sodium excretion and the volume of body fluids 
underlie the development of arterial hyperten-
sion. One of the hypotheses assumes that sodium- 
-sensitive hypertension results mainly from ac-
quired minor damage to the renal interstitium 
whereby kidney function remains unchanged or 
only slightly impaired, while urinalysis results are 
normal or indicate only albuminuria [6]. There-
fore, arterial hypertension diagnosed as primary 
may in fact be a manifestation of functional and 
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Mean arterial pressure was calculated from the 
formula:
MAP (mmHg) = DBP + 1/3 × (SBP – DBP) 
Pulse pressure was calculated from the formula:
PP (mmHg) = SBP – DBP
All subjects underwent echocardiographic ex-
amination of the heart, ultrasound examination of 
carotid arteries to determine IMT, and analysis of 
PWV and pulse waveform.
Echocardiographic examination
Echocardiographic examination was performed 
using ALOKA SSD-3500SV ultrasound scanner 
with the transducer set at the frequency of 2.5 MHz. 
Left ventricular mass (LVM) was calculated using 
the formula introduced by Devereux et al. [7]. Left 
ventricular mass index (LVMI) was calculated as the 
ratio of LVM to body surface area (BSA). Mitral 
valve flow was recorded using pulsed-wave Doppler 
ultrasound, in an apical four-chamber view, with the 
sample volume placed at the tips of open mitral valve 
leaflets. In this manner, the following mitral flow 
parameters were measured:
•	 E — early filling peak velocity (m/s), and
•	 A  — peak flow velocity during atrial systole 
(m/s).
E/A  ratio was calculated from the obtained pa-
rameters.
Ultrasound examination  
of the carotid arteries
Ultrasound examination of the carotid arteries was 
performed using ALOKA SSD-3500SV ultrasound 
scanner with the transducer set at the frequency of 
7.5 MHz. The measurement was taken in areas with 
no atherosclerotic plaque in the common carotid 
artery, the carotid sinus and the cervical segment of 
the internal carotid artery, displaying at least 10 mm 
of the length of the examined fragment. IMT was 
calculated as the arithmetic mean of 6 measurements.
Pulse wave analysis
Analysis of PWV and pulse waveform was per-
formed by applanation tonometry using the Sphyg-
moCor SCOR-PVx no. 01213 system. Applanation 
tonometer no. 318858 was used to detect pulse wave.
Pulse wave velocity
PWV was measured by consecutively recording 
pulse wave in the carotid and femoral arteries, and 
measuring the distance between the measurement 
points and the jugular notch. The system’s software 
then morphological damage to the kidneys which 
occurs subclinically.
The aim of the study was:
1.  an assessment of the correlations of conventio-
nal arterial pressure measurement in the brachial 
artery and non-invasive central aortic pressure 
measurement by applanation tonometry with:
•	 the structure and function of arterial vessels and 
the left ventricle of the heart,
•	 selected parameters of renal filtration function 
and the renal interstitium;
2.  an attempt at finding correlations of morpholo-
gical and functional changes in the cardiovascular 
system with selected parameters of renal filtration 
function and the renal interstitium in patients 
with previously untreated primary arterial hyper-
tension.
Material and methods
The study was performed on a  group of 25 pa-
tients (9 women and 16 men) aged 21–61 with 
previously untreated primary arterial hypertension. 
The criteria for exclusion were: secondary arterial 
hypertension, eGFR < 60 ml/min/1.73 m2, albu-
minuria, erythrocyturia, diabetes, systemic diseases, 
neoplastic disease, lack of patient consent to partici-
pate in the study.
The control group consisted of 15 healthy volun-
teers (6 women and 9 men) with normal arterial 
pressure values, whose age matched that of the stud-
ied group. The study protocol KB/447/2006 was 
approved by the Bioethics Committee of the Nico-
laus Copernicus University Collegium Medicum in 
Bydgoszcz.
Each patient underwent a  physical examination 
and an interview in outpatient conditions. Arterial 
blood pressure was measured using a mercury sphyg-
momanometer after no less than 10 minutes’ rest 
in sitting position in a  quiet room. The first and 
fifth Korotkoff sounds were used to determine the 
values of systolic and diastolic arterial pressure, re-
spectively. Arterial pressure measurement was taken 
using a cuff whose length and width were adjusted 
to the arm circumference. Arterial hypertension was 
diagnosed when mean values of arterial pressure (cal-
culated from at least two measurements taken during 
two separate visits) were equal to or higher than 
140 mmHg for systolic pressure and/or 90 mmHg 
for diastolic pressure. The measurements were then 
used to calculate mean arterial pressure (MAP) and 
pulse pressure (PP).
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measured the time interval between R-wave peak in 
the electrocardiogram and the foot of the pulse wave 
(intersecting tangents) for both examined arteries. 
Time (t) between the occurrence of pulse wave in 
the carotid and femoral arteries was measured au-
tomatically. Pulse wave distance (d) was calculated 
form the formula: d = (distance between the jugular 
notch of the sternum and the measurement point on 
the femoral artery) — (distance between the jugular 
notch of the sternum and the measurement point on 
the carotid artery). Distances were measured using 
a  measuring tape. PWV was calculated using the 
equation PWV = d/t and expressed in (m/s). The 
criterion for the validity of the study was accepted as 
standard deviation of the said measurements lower 
than 6%, and standard deviation of the calculated 
PWV lower than 10%.
Central pressure and other  
pulse wave parameters
Central pressure, augmentation pressure (AP) and 
augmentation index (AIx) were calculated by mathe-
matical analysis — the so-called transfer function 
— detecting the pulse wave of the radial artery for 
at least 12s. An application in the device performed 
aortic waveform reconstruction. Before recording 
pulse wave in the radial artery, arterial pressure in 
the brachial artery was measured using the oscillo-
metric method.
Laboratory testing
In the subsequent stage, subjects participating 
in the study were instructed in terms of perfor-
ming a 24-hour urine collection. 24-hour creatinine 
clearance, uric acid clearance and albuminuria were 
analysed in 24-hour urine samples on the day of 
their collection. The remaining portion of urine 
was centrifuged and frozen at –70°C for further 
determination of N-acetyl-beta-D-glucosaminidase 
(NAG).
On the day following the 24-hour urine collec-
tion, the subjects underwent a peripheral blood draw 
after overnight fasting. On the day of the blood 
draw, a  portion of the serum was analysed for the 
concentration of glucose, creatinine and uric acid. 
The remaining portion of serum was apportioned 
into Eppendorf test tubes and frozen at –70°C for 
further analysis, i.e. the concentration of erythro-
poietin, 25-hydroxycholecalciferol [25(OH)D3] and 
1,25-dihydroxycholecalciferol [1,25(OH)2D3].
Glomerular filtration rate (eGFR) was estimated 
using the Modification of Diet in Renal Disease 
(MDRD) formula [8]:
eGFR (ml/min/1.73 m2) = 186 × (creatinine concentration)–1,154 × (age)–0,203 × C
Fractional uric acid excretion — FEUA (%) was 
calculated from the formula:
FEUA (%) = UAur/UAs × Crs/Crur × 100
where:
UAur — concentration of uric acid in urine
UAs — concentration of uric acid in serum
Crs — concentration of creatinine in serum
Crur — concentration of creatinine in urine
Statistical analysis
The obtained results were analysed statistically. 
The compliance of the distribution of variables with 
normal distribution was analysed using the Sha piro-
-Wilk test. Student’s t-test for independent variables 
was used to compare mean values for samples with 
close-to-normal distribution. Variance homogene-
ity was assessed using Levene’s test. When the distri-
bution was significantly different from normal, the 
significance of differences between groups was de-
termined using the Mann-Whitney nonparametric 
U test. Correlation between two variables was cal-
culated using the Pearson and Spearman correlation 
coefficient. The multiple regression method was 
used to analyse the cumulative effect of multiple 
variables on the dependent variable. The statistical 
significance level was accepted as p < 0.05. All cal-
culations were performed using the Statistica 7.1 
software.
Results
Clinical characteristics of subjects from the group 
with arterial hypertension and from the control 
group are presented in Tables I–V.
Data presented in Tables II–III demonstrate that 
no statistically significant differences were found 
with respect to the values of selected parameters of 
renal filtration function and the renal interstitium 
between the studied groups. 24-hour excretion of 
NAG in urine was at the borderline of statistical 
significance.
In the group of hypertensive subjects, a statistical-
ly significant lower value of the E/A ratio was found 
as compared to the control group.
Data presented in Tables VI–VII show that statis-
tically significant positive correlations of CPP with 
IMT and AIx values were found both in the group of 
hypertensive patients and the control group. More-
over, a  statistically significant negative correlation 
between CPP and E/A ratio was found in the group 
of hypertensive subjects.
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Table I. Basic characteristics of the studied groups
Parameter
Studied group
n = 25
Control group
n = 15 P
Mean SD Mean SD
Age (years) 43.52 11.55 40.67 10.90 0.4448
BMI [kg/m2] 28.72 4.00 25.04 4.00 0.0076
SBP [mmHg] 163.40 13.05 119.00 9.10 0.0001
DBP [mmHg] 101.20 9.60 77.67 6.51 0.0001
MAP [mmHg] 121.88 9.75 91.47 6.62 0.0001
PP [mmHg] 62.20 10.42 41.33 7.43 0.0001
CSP [mmHg] 144.32 19.59 114.20 9.37 0.0001
CDP [mmHg] 101.80 10.79 83.80 7.09 0.0001
MCAP [mmHg] 115.90 13.20 93.90 6.80 0.0001
CPP [mmHg] 42.52 11.97 30.40 8.93 0.0016
In the group of hypertensive subjects, increased values of the following were found: BMI, SBP and DBP measured conventionally in the brachial artery, as well as MAP and PP.  
Moreover, increased values of CSP, CDP, MCAP and CPP were found in the group of hypertensive subjects.  
Abbreviations: BMI — body mass index, CDP — central diastolic pressure, CPP — central pulse pressure, CSP — central systolic pressure, DBP — diastolic blood pressure, MAP — mean arterial pressure, MCAP — 
mean central arterial pressure, PP — pulse pressure, SBP — systolic blood pressure
Table II. Concentration of creatinine and uric acid in serum, fractional uric acid excretion (FEUA) and estimated glomerular filtration rate 
(eGFR) in the studied and the control group
Parameter Studied group
n = 25
Control group
n = 15 P
Mean SD Mean SD
Creatinine [mg%] 0.87 0.14 0.90 0.17 0.5889
eGFR [ml/min/1.73 m2] 94.42 14.56 91.76 12.37 0.5579
Uric acid [mg%] 4.64 1.56 4.19 1.12 0.3339
FEUA (%) 5.00 4.12 5.71 2.77 0.5603
Table III. 24-hour NAG excretion in urine, concentration of erythropoietin, vitamin 25(OH)D3 and 1,25(OH)2D3 in serum in the studied  
and the control group
Parameter Studied group
n = 25
Control group
n = 15 P
Median Range Median Range
NAG [IU/g creat.] 2.24 0.12–8.74 1.28 0.13–2.41 0.0792
Erythropoietin [ug/ml] 3.55 0.24–47.77 4.03 0.24–101.00 0.6957
25(OH)D3 [ng/ml] 15.10 7.16–48.70 16.00 9.68–40.50 0.5859
1,25(OH)2D3 [pg/ml] 51.50 26.40–88.40 49.80 29.50–90.60 0.9889
1,25(OH)2D3/25(OH)D3 3.03 1.36–8.67 3.26 1.58–6.25 0.8779
In the group of hypertensive patients, a statistical-
ly significant moderate positive correlation was found 
between aortic PWV and 24-hour NAG excretion 
(R = 0.46, p = 0.019). The correlation is presented 
in Figure 1. No such correlation was found in the 
control group.
In the group of hypertensive patients, a moderate 
positive correlation at the borderline of statistical 
significance was found between IMT and 24-hour 
NAG excretion (R = 0.46, p = 0.078). The correla-
tion is presented in Figure 2. No such correlation was 
found in the control group.
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Table IV. Left ventricular ejection fraction (EF), left ventricular mass index (LVMI) and ratio of early (E) to late (A) ventricular filling  
velocities (E/A) in the studied and the control group
Parameter Studied group
n = 25
Control group
n = 15 P
Mean SD Mean SD
EF (%) 65.20 2.22 65.47 1.36 0.6770
LVMI [g/m2] 96.77 18.59 88.81 16.67 0.1814
E/A 1.09 0.26 1.28 0.19 0.0210
Table V. Parameters of vascular structure and function in the studied and the control group.
Parameter Studied group
n = 25
Control group
n = 15 P
Mean SD Mean SD
IMT [mm] 0.73 0.19 0.53 0.11 0.0011
PWV [m/s] 7.86 1.60 6.50 1.12 0.0065
AIx (%) 24.60 13.19 15.73 13.46 0.0480
AP [mmHg] 11.76 7.77 6.33 5.29 0.0220
Hypertensive subjects demonstrated statistically significant higher values of IMT, aortic PWV, AIx and AP than the control group. 
Abbreviations: Aix — augmentation index, AP — augmentation pressure, IMT — intima-media thickness, PWV — pulse wave velocity
Table VI. Spearman’s correlation coefficients between PP and parameters of vascular and left ventricular structure and function in the 
studied and the control group
Linear correlations Studied group
n = 25
Control group
n = 15
R P R P
PP vs IMT 0.04 0.833 –0.09 0.752
PP vs PWV 0.15 0.473 0.31 0.262
PP vs AIx 0.10 0.626 –0.29 0.289
PP vs EF –0.03 0.886 –0.36 0.184
PP vs LVMI –0.02 0.937 0.19 0.496
PP vs E/A  –0.06 0.762 –0.09 0.740
A multiple regression analysis was carried out (Ta-
bles VIII–X) in which the relationship was studied 
of vascular structure and function parameters (PWV, 
IMT), eGFR and uric acid concentration in serum 
with the rate of 24-hour NAG excretion.
The multiple regression equation is as follows:
NAG = –5.39 + 5.00 × IMT + 0.51 × PWV
In the group of hypertensive patients, the statisti-
cally significant model (p = 0.00045) considers only 
two independent variables. The correlation between 
24-hour NAG excretion and IMT is statistically sig-
nificant (p = 0.0048) with a mean increase in NAG 
by 5 IU/g creatinine and a  concomitant increase 
in IMT by 1 mm. Also, the correlation between 
24-hour NAG excretion and PWV is statistically sig-
nificant (p = 0.0158) with a mean increase in NAG 
by 0.51 IU/g creatinine and a concomitant increase 
in PWV by 1 m/s. Standard error of estimation 
was 1.60 for IMT and 0.19 for PWV. The R2 value 
of 0.503 indicates that 50.3% of the variation of 
24-hour NAG excretion is explained by the differ-
ences in IMT and PWV values. 
The additional incorporation of the value of eGFR 
or uric acid concentration in serum into the model 
does not have a  statistically significant effect on 
the dependent variable NAG (p = 0.9307 and 
p = 0.4938, respectively) (Tables IX and X).
In the control group, the abovementioned pa-
rameters have no statistically significant effect on the 
value of 24-hour NAG excretion.
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Table VII. Spearman’s correlation coefficients between CPP and parameters of vascular and left ventricular structure and function  
in the studied and the control group
Linear correlations Studied group
n = 25
Control group
n = 15
R P R P
CPP vs IMT 0.47 0.019 0.63 0.011
CPP vs PWV 0.13 0.544 0.33 0.234
CPP vs AIx 0.63 0.001 0.60 0.005
CPP vs EF 0.12 0.553 –0.16 0.480
CPP vs LVMI 0.33 0.103 –0.12 0.669
CPP vs E/A  –0.47 0.019 –0.00 0.985
Table VIII. Multiple regression analysis for the dependent variable 
NAG in the studied group
Dependent variable: NAG [UI/g Cr] R2 = 0.503
Independent variables BETA BETA error P
IMT [mm] 0.49 0.16 0.0048
PWV [m/s] 0.41 0.16 0.0158
Table IX. Multiple regression analysis for the dependent variable 
NAG with regard to eGFR in the studied group
Dependent variable: NAG [UI/g Cr] R2  = 0.514
Independent variables BETA BETA error P
IMT [mm] 0.47 0.16 0.0079
PWV [m/s] 0.42 0.16 0.0148
eGFR [ml/min/1.73 m2] 0.11 0.15 0.4937
Table X. Multiple regression analysis for the dependent variable 
NAG with regard to uric acid concentration in blood serum  
in the studied group
Dependent variable: NAG [UI/g Cr] R2 = 0.503
Independent variables BETA BETA error P
IMT [mm] 0.48 0.16 0.0062
PWV [m/s] 0.41 0.16 0.0192
Uric acid [mg/dl] -0.01 0.16 0.9307
Discussion
The results of the present study confirm the ob-
servations to date whereby the values of SBP and PP 
are higher in the brachial artery as compared to CSP 
and CPP in both the group of hypertensive subjects 
and the control group (Table I).
An increase in SBP and PP values along the course 
of vessels from the heart to the periphery called the 
augmentation phenomenon results from:
•	 the propagation of pulse wave through the vas-
cular bed characterized by vascular diameter re-
duction and the transition from elastic arteries 
to muscular arteries, and
•	 the interference between reflected and incident 
waves resulting from blood being ejected from 
the left ventricle and flowing in the direction 
opposite to the wave reflected from arterial bi-
furcations and choke vessels.
In physiological conditions, provided that arterial 
wall elasticity is maintained, the velocity of a pulse 
wave is relatively low. Thus, the reflected wave re-
turns to the ascending aorta in diastole, increasing 
CDP and the flow of blood through coronary vessels 
[9]. An increase in arterial wall stiffness, leading to 
an increase in PWV, results in an earlier return of 
the reflected wave which reaches the ascending aorta 
and thus induces an increase in CSP. This in turn 
results in an increase in the left ventricular afterload 
and a  disturbance in the blood flow in coronary 
vessels [9]. The described pathophysiological mech-
anism may be considered an argument supporting 
the assumption that central pressure has a  higher 
predictive value for the occurrence of cardiovascular 
events than pressure measured conventionally in the 
brachial artery.
Central pulse pressure is considered to be one of 
the major indicators associated with cardiovascular 
complications [10]. Analysis of results of the present 
study shows that in both the group of hypertensive 
patients and the control group statistically significant 
positive correlations were determined between CPP 
and the values of IMT and AIx (Table VII). Such 
correlations were not found with respect to periph-
eral pulse pressure in the brachial artery (Table VI). 
An increase in IMT, considered to be an early stage 
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Figure 1. Correlation between 24-hour NAG excretion and PWV in the studied and the control group
Figure 2. Correlation between 24-hour NAG excretion and IMT in the studied and the control group
of atherosclerosis, was recognized as an indicator 
of the atherosclerotic process taking place in other 
arteries [11].
Research study carried out by Boutouyrie et al. 
[12] on a group of subjects with normal arterial pres-
sure values and patients with previously untreated 
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primary arterial hypertension revealed that CPP in 
the carotid artery, measured by applanation tonome-
try, proved to be a reliable indicator of its distensibi-
lity and thickness in comparison to PP in the brachial 
artery and MAP. The determination of a correlation 
between IMT and PP in an elastic artery, such as 
the carotid artery, which has not been observed with 
respect to the radial artery, may indicate the involve-
ment of cyclically changing vascular wall tension in 
the process of vascular remodelling [12].
A metaanalysis of 11 prospective research studies 
investigating the correlation between central pressure 
and patient prognosis showed that an increase in 
CSP and CPP by 10 mmHg entailed an increase in 
the risk of the occurrence of a total number of fatal 
and nonfatal cardiovascular events by 8.8% for CSP 
and by 13.7% for CPP [13]. The additional predic-
tive value of CPP as compared to PP in the brachial 
artery was only marginal and statistically insignifi-
cant (p = 0.057) [13].
Attention should be drawn to the fact that the 
present study revealed increased, at the borderline 
of statistical significance, 24-hour excretion of NAG 
in the group of hypertensive patients as compared to 
the control group (Table III). NAG is a  lysosomal 
enzyme exhibiting particularly high activity in proxi-
mal tubule cells. Due to its high molecular weight 
— about 140,000 Da — it does not pass through 
the filter of a  normal glomerular basement mem-
brane [14]. NAG activity assessment can be applied 
as a sensitive and early indicator of proximal tubule 
damage. Consequently, increased excretion of NAG 
in hypertensive patients may be indicative of renal 
tubular defect. The present study failed to determine 
whether this is a consequence of arterial hypertension 
or whether its occurrence was preceded by interstitial 
damage. Arterial hypertension diagnosed in the said 
group of patients as primary may in fact be a con-
sequence of slight damage to renal tubules whereby 
glomerular filtration is not impaired and urinalysis 
results are normal.
Cowley et al. suggest that what underlies arterial 
hypertension development are hemodynamic disor-
ders leading to microcirculation disorders within the 
renal medulla [15]. Positive correlations of IMT and 
PWV with 24-hour NAG excretion discovered in 
the present study may indicate concomitant damage 
to renal tubules along with an impairment of vascu-
lar morphology and function. It is worth devoting 
attention to studies which examined the correlation 
of IMT with the value of the resistive index (RI) in 
intrarenal vessels [16] or the presence of albuminu-
ria. Bigazzi et al. found a strong positive correlation 
between IMT and albuminuria [17], which has not, 
however, been confirmed by other authors [18].
A  study by Takiuchi et al. [19] on a  group of 
patients with primary arterial hypertension revealed 
a statistically significant positive correlation of IMT 
with albuminuria, the progression of hypertensive 
retinopathy and LVMI. One of the mechanisms un-
derlying the coexistence of micro- and macroan-
giopathic changes in those patients might be the 
involvement of a chronic inflammatory response. 
A parameter indicating early changes in the course 
of arterial hypertension is the RI of intrarenal ves-
sels. An increase in its value reflects an increase in 
flow resistance of the renal circulation resulting from 
the stiffening of small arterioles. Therefore, revealing 
the correlation between IMT and RI in patients 
with untreated primary arterial hypertension [16] 
indirectly contributes to explaining the correlation 
between IMT and 24-hour NAG excretion found in 
the present study.
The performed multiple regression analysis 
showed that the parameter which had the strongest 
effect on the dependent variable NAG in the group 
of hypertensive patients were the values of PWV and 
IMT. Uric acid concentration in serum and eGFR 
showed a marginal, statistically insignificant effect on 
the dependent variable NAG (Tables VIII–X).
Another parameter determining the functional 
status of the tubulointerstitial tissue is hormone 
concentration in serum: vitamin 1,25(OH)2D3 and 
erythropoietin. The kidneys provide the basic source 
of 1,25(OH)2D3 and erythropoietin in the organism. 
25(OH)D3 is hydroxylated in position 1 in the pro-
ximal tubule mitochondria, whereas erythropoietin 
is produced mainly by periurethral cells and fibro-
blasts on the border between the renal cortex and 
the outer region of the renal medulla. The present 
study found no statistically significant differences in 
1,25(OH)2D3 and erythropoietin concentration in 
serum between the studied groups. 
The role of vitamin D3 and its relationship with 
arterial hypertension are not entirely clear. What 
testifies to the role of vitamin D3 in arterial pressure 
regulatory processes is the fact that receptors for vita-
min D3 are located in organs participating in arterial 
pressure regulation, that is in the central nervous sys-
tem, the kidney, adrenal glands, vascular wall, or the 
heart [20]. By affecting immune system constituents, 
vitamin D3 may exert an indirect effect on arterial 
pressure regulation and the occurrence of cardiovas-
cular diseases. Its influence on the immune system 
manifests in an inhibitory effect on the maturation of 
antigen-presenting cells [21] and a modulatory effect 
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on the profile of secreted cytokines. It triggers, inter 
alia, an increase in the production of IL-10 and a de-
crease in the production of IL-6, IL-12, INF-g and 
TNF-a [22]. This in turn contributes to a decrease 
in the production of superoxides and acute-phase 
proteins, including CRP, and in the proliferation of 
vascular smooth muscle cells, and has a  protective 
effect on the vascular endothelium.
Conclusions
1. Damage to the renal tubulointerstitial tissue is 
concomitant with a  decrease in vascular resis-
tance in patients with untreated primary arterial 
hypertension.
2. An increase in NAG excretion in urine under 
normoalbuminuria and normal glomerular fil-
tration rates may be indicative of damage to the 
renal tubulointerstitial tissue preceding damage 
to glomeruli in those patients.
3. Central pulse pressure may be a useful parameter 
for assessing the development of atherosclerotic 
lesions in vessels and the function of the left ven-
tricle of the heart.
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